BRAINSTORM CELL THERAPEUTICS INC. Accounts Receivable
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) had Accounts Receivable of $449.00 thousand as of 2012-09-30, per its 10-Q filed 2012-11-13.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2012-11-13
- 2012-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $449.00K.
- 2012-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $421.00K.
- 2012-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $482.00K.
- 2011-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $312.00K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2012-09-30 | $449.00K 10-Q · filed 2012-11-13 |
| 2012-06-30 | $421.00K 10-Q/A · filed 2012-08-29 |
| 2012-03-31 | $482.00K 10-Q · filed 2012-05-11 |
| 2011-12-31 | $312.00K 10-Q · filed 2012-11-13 |
| 2011-09-30 | $369.00K 10-Q · filed 2011-11-14 |
| 2010-12-31 | $427.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |